Existing studies had reported that JPXK prescription could increase fasting insulin (FINS), reduce insulin resistance (IR), and enhance islet cell function in diabetic rats, as associated with AMPK/mROC1/SAD-A signaling pathway [2]. This evidence concerns the gene INS and Insulin resistance.